Genetronics develops electrochemotherapy treatment
This article was originally published in Clinica
Executive Summary
Genetronics (US) has developed a treatment for malignant tumours by combining electrical stimuli with chemotherapy. Electroporation causes pores in dermal cell membranes to admit a higher concentration of cytostatic agents via needle electrodes inserted around the tumour than would normally enter.